Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1854 1
1877 1
1889 1
1891 2
1894 1
1915 1
1935 1
1940 1
1942 1
1946 1
1948 1
1949 1
1954 1
1955 1
1964 1
1979 1
1984 1
1985 2
1988 2
1990 2
1993 3
1994 1
1996 3
1997 2
1998 2
1999 1
2000 3
2001 6
2002 5
2003 6
2004 5
2005 5
2006 9
2007 6
2008 4
2009 4
2010 6
2011 7
2012 10
2013 8
2014 12
2015 8
2016 12
2017 8
2018 6
2019 12
2020 9
2021 11
2022 7
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 28209678

189 results

Results by year

Filters applied: . Clear all
Page 1
Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
Shinefield H, Black S, Thear M, Coury D, Reisinger K, Rothstein E, Xu J, Hartzel J, Evans B, Digilio L, Schödel F, Brown ML, Kuter B; 013 Study Group for ProQuad. Shinefield H, et al. Pediatr Infect Dis J. 2006 Apr;25(4):287-92. doi: 10.1097/01.inf.0000207857.10947.1f. Pediatr Infect Dis J. 2006. PMID: 16567978 Clinical Trial.
Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT.
Le Saux N, Barrowman NJ, Moore DL, Whiting S, Scheifele D, Halperin S; Canadian Paediatric Society/ Health Canada Immunization Monitoring Program-Active (IMPACT). Le Saux N, et al. Pediatrics. 2003 Nov;112(5):e348. doi: 10.1542/peds.112.5.e348. Pediatrics. 2003. PMID: 14595075
The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine.
Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, DeStefano F, Chen RT, Immanuel V, Pearson JA, Vadheim CM, Rebolledo V, Christakis D, Benson PJ, Lewis N; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group. Barlow WE, et al. N Engl J Med. 2001 Aug 30;345(9):656-61. doi: 10.1056/NEJMoa003077. N Engl J Med. 2001. PMID: 11547719 Free article.
Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months.
Vesikari T, Karvonen A, Lindblad N, Korhonen T, Lommel P, Willems P, Dieussaert I, Schuerman L. Vesikari T, et al. Pediatr Infect Dis J. 2010 Jun;29(6):e47-56. doi: 10.1097/INF.0b013e3181dffabf. Pediatr Infect Dis J. 2010. PMID: 20508478 Clinical Trial.
Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months.
Usonis V, Meriste S, Bakasenas V, Lutsar I, Collard F, Stoffel M, Tornieporth N. Usonis V, et al. Vaccine. 2005 Apr 8;23(20):2602-6. doi: 10.1016/j.vaccine.2004.11.062. Vaccine. 2005. PMID: 15780442 Clinical Trial.
189 results